Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
434 questions in 75 reviews · Metabolic and Endocrine Disorders
current versionsNo studies 434 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Non‐fatal myocardial infarction, non‐fatal stroke, congestive heart failure · people at risk for the development of type 2 diabetes mellitus Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · people at risk for the development of type 2 diabetes mellitus Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · people at risk for the development of type 2 diabetes mellitus Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications… (2016) · Cochrane | no estimate extracted | NR | No studies |
Short‐acting insulin analogues vs regular human insulin All‐cause mortality Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Short‐acting insulin analogues vs regular human insulin Macrovascular complications Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Short‐acting insulin analogues vs regular human insulin Microvascular complications Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Short‐acting insulin analogues vs regular human insulin Health‐related quality of life Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Short‐acting insulin analogues vs regular human insulin Costs Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · obese children and adolescents Drug interventions for the treatment of obesity in children and adolescents (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of type 2 diabetes mellitus · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetic complications · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · non‐diabetic adults with insulin resistance Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance (2015) · Cochrane | no estimate extracted | NR | No studies |
Total or near‐total thyroidectomy vs subtotal thyroidectomy Health‐related quality of life Total or near‐total thyroidectomy versus subtotal thyroidectomy for multinodular non‐toxic goitre in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Total or near‐total thyroidectomy vs subtotal thyroidectomy Socioeconomic effects Total or near‐total thyroidectomy versus subtotal thyroidectomy for multinodular non‐toxic goitre in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Total thyroidectomy vs bilateral subtotal thyroidectomy Health‐related quality of life Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Total thyroidectomy vs bilateral subtotal thyroidectomy Socioeconomic effects Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Bilateral subtotal thyroidectomy vs the Dunhill procedure Health‐related quality of life Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Bilateral subtotal thyroidectomy vs the Dunhill procedure Socioeconomic effects Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Total thyroidectomy vs subtotal thyroidectomy Health‐related quality of life Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Total thyroidectomy vs subtotal thyroidectomy Socioeconomic effects Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Final height · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Near‐final height · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs waiting list control Health‐related quality of life · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs waiting list control All‐cause mortality · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs waiting list control Morbidity · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs waiting list control Socioeconomic effects · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs minimal contact control Adverse events · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs minimal contact control All‐cause mortality · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs minimal contact control Morbidity · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐child interventions Adverse events · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs minimal contact control Socioeconomic effects · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐only interventions Adverse events · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐only interventions Health‐related quality of life · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐only interventions All‐cause mortality · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐only interventions Morbidity · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐only interventions Socioeconomic effects · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐child interventions Health‐related quality of life · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐child interventions All‐cause mortality · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐child interventions Morbidity · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐child interventions Parent‐child relationship or assessment of parenting · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs parent‐child interventions Socioeconomic effects · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Parent‐only interventions vs waiting list control Adverse events · children with overweight or obesity Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years (2015) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding Serious adverse events (SAEs) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open) Serious adverse events (SAEs) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |